CEL-SCI Reports CRADA with Naval Medical Center in San Diego

CEL-SCI Corporation (NYSE: CVM ) today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Center, San Diego. Pursuant to this agreement, the US Naval Medical Center, San Diego will conduct a Human Subjects Institutional Review Board approved Phase I dose escalation study of CEL-SCI's investigational